Register entry
Patheon Manufacturing Services LLC
Data as of · How to read this entry
- Registered sites
- 19
- Active NDC listings
- 318
- Labeller names
- 10
- Live patents
- 0
- Countries
- 9
- Base
- United States
Authorisation
Registered operations
Analytical testing17Active ingredient (API) manufacture6Labelling11Finished drug manufacture15Packaging12sterilize3
Sites
Registered establishments
19| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Patheon Biologics Australia Pty LtdRegistrant: Patheon Manufacturing Services LLC | 37 Kent Street, Woolloongabba, Queensland 4102, Australia (AUS) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3010976475743194888 |
| Patheon Austria GmbH & CoKGRegistrant: Patheon Manufacturing Services LLC | St.-Peter-Strasse 25, Linz, 4020, Austria (AUT) | Analytical testing, Active ingredient (API) manufacture | 3002806853300398976 |
| Patheon Inc.Registrant: Patheon Manufacturing Services LLC | 95 Market Dr, Milton, Ontario L9T 4Z7, Canada (CAN) | Finished drug manufacture | 3047706967243370117 |
| Patheon Inc.Registrant: Patheon Manufacturing Services LLC | 2100 Syntex Court, Mississauga, Ontario L5N 7K9, Canada (CAN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3000264888240769596 |
| Patheon Inc.Registrant: Patheon Manufacturing Services LLC | 111 Consumers Drive, Whitby, Ontario L1N 5Z5, Canada (CAN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003516812205475333 |
| Patheon France S.A.SRegistrant: Patheon Manufacturing Services LLC | 40 Boulevard de Champaret, Bourgoin Jallieu, - 38 300, France (FRA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3004468553543127229 |
| Patheon UK LimitedRegistrant: Patheon Manufacturing Services LLC | Kingfisher Drive, Swindon, Sn3 5bz, United Kingdom (GBR) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3002807216237710418 |
| Thermo Fisher Scientific Cork LimitedRegistrant: Patheon Manufacturing Services LLC | Currabinny, Carrigaline, Cork P43 AY66, Ireland (IRL) | Analytical testing, Active ingredient (API) manufacture | 1000170338985745028 |
| Patheon Italia S.p.ARegistrant: Patheon Manufacturing Services LLC | 2� Trav. SX Via Morolense, 5, Ferentino, - 03013, Italy (ITA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3004110157434078638 |
| Patheon Italia S.p.A.Registrant: Patheon Manufacturing Services LLC | Viale Gian Battista Stucchi 110, Monza, - 20900, Italy (ITA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3003065803338336589 |
| Patheon Biologics B.V.Registrant: Patheon Manufacturing Services LLC | Zuiderweg 72/2, Groningen, AP 9744, Netherlands (NLD) | Analytical testing, Active ingredient (API) manufacture | 3002608687419364153 |
| Patheon Softgels B.V.Registrant: Patheon Manufacturing Services LLC | De Posthoornstraat 7, Tilburg, Tilburg 5048 AS, Netherlands (NLD) | Analytical testing, Finished drug manufacture | 1000384811417524097 |
| Patheon Pharmaceuticals Inc.Registrant: Patheon Manufacturing Services LLC | 2110 E Galbraith Rd., Cincinnati, Ohio (OH) 45237, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 1510437005286822 |
| Patheon Biologics LLC | 13600 Shoreline Drive, Earth City, Missouri (MO) 63045-1203, United States (USA) | Finished drug manufacture | 3032073937119085689 |
| Patheon Manufacturing Services LLC | 5900 Martin Luther King Jr. Highway, Greenville, North Carolina (NC) 27834, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1018495079415560 |
| Patheon Softgels Inc.Registrant: Patheon Manufacturing Services LLC | 4125 Premier Dr, High Point, North Carolina (NC) 27265, United States (USA) | Analytical testing, Finished drug manufacture, Packaging | 3001451366002193829 |
| Patheon Puerto Rico, Inc.Registrant: Patheon Manufacturing Services LLC | State Road #670 Km. 2.7, Manati, Puerto Rico (PR) 00674, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003113148174050377 |
| Patheon Manufacturing Services LLC | 1125 Pleasantview Ter, Ridgefield, New Jersey (NJ) 07657, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 2246315062331516 |
| Patheon Biologics LLC | 4766 LaGuardia Drive, Saint Louis, Missouri (MO) 63134-3116, United States (USA) | Analytical testing, Active ingredient (API) manufacture | 3003418999965750420 |
Catalogue
Drug listings by form and route
318318 active NDC listings: 316 drug for further processing, 2 vaccine. By marketing category: DRUG FOR FURTHER PROCESSING 317, BLA 1.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 85 |
| tablet | 54 |
| capsule | 40 |
| injection | 21 |
| injection, powder, lyophilized, for solution | 14 |
| solution | 14 |
| tablet, coated | 13 |
| injection, solution | 12 |
| capsule, gelatin coated | 9 |
| kit | 9 |
| tablet, extended release | 7 |
| tablet, film coated, extended release | 7 |
| capsule, coated pellets | 4 |
| granule, for suspension | 3 |
| tablet, chewable | 3 |
| Route | NDCs |
|---|---|
| intramuscular | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| patheon inc. | 111 |
| patheon manufacturing services llc | 99 |
| patheon pharmaceuticals inc. | 40 |
| patheon france s.a.s. | 26 |
| patheon, inc. | 18 |
| patheon france s.a.s | 17 |
| patheon biologics llc | 3 |
| patheon uk limited | 2 |
| patheon biologics b.v. | 1 |
| patheon france s.a.s | 1 |
Catalogue
Marketed products
319Showing 150 of 319.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | injection | 63552-187DRUG FOR FURTHER PROCESSING |
| - | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | injection | 63552-210DRUG FOR FURTHER PROCESSING |
| - | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | injection | 63552-213DRUG FOR FURTHER PROCESSING |
| - | ACETAZOLAMIDE SODIUM | injection, powder, lyophilized, for solution | 63552-116DRUG FOR FURTHER PROCESSING |
| - | AFLIBERCEPT-JBVF | injection | 63552-281DRUG FOR FURTHER PROCESSING |
| - | ALTEPLASE | injection, powder, lyophilized, for solution | 63552-041DRUG FOR FURTHER PROCESSING |
| - | ANAGRELIDE HYDROCHLORIDE | capsule | 63552-005DRUG FOR FURTHER PROCESSING |
| - | APREMILAST | tablet, film coated | 66406-0240DRUG FOR FURTHER PROCESSING |
| - | APREMILAST | tablet, film coated | 66406-0241DRUG FOR FURTHER PROCESSING |
| - | APREMILAST | tablet, film coated | 66406-0242DRUG FOR FURTHER PROCESSING |
| - | AVACOPAN | capsule | 67651-0363DRUG FOR FURTHER PROCESSING |
| - | AVACOPAN | capsule | 67651-0364DRUG FOR FURTHER PROCESSING |
| - | Adagrasib | tablet, coated | 47049-043DRUG FOR FURTHER PROCESSING |
| - | Avapritinib | tablet, film coated | 63285-868DRUG FOR FURTHER PROCESSING |
| - | Avapritinib | tablet, film coated | 63285-869DRUG FOR FURTHER PROCESSING |
| - | CARBAMAZEPINE | tablet | 63552-060DRUG FOR FURTHER PROCESSING |
| - | COLISTIMETHATE SODIUM | injection, powder, lyophilized, for solution | 63552-010DRUG FOR FURTHER PROCESSING |
| - | Carfilzomib | injection, powder, lyophilized, for solution | 63552-009DRUG FOR FURTHER PROCESSING |
| - | Carfilzomib | injection, powder, lyophilized, for solution | 63552-035DRUG FOR FURTHER PROCESSING |
| - | Carfilzomib | injection, powder, lyophilized, for solution | 63552-214DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE | capsule, extended release | 63552-129DRUG FOR FURTHER PROCESSING |
| - | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE | capsule, extended release | 63552-130DRUG FOR FURTHER PROCESSING |
| - | DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE | tablet, multilayer, extended release | 66406-0336DRUG FOR FURTHER PROCESSING |
| - | DEXTROMETHORPHAN HYDROBROMIDE and BUPROPION HYDROCHLORIDE | tablet, multilayer, extended release | 66406-0467DRUG FOR FURTHER PROCESSING |
| - | Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide | tablet, film coated | 63285-816DRUG FOR FURTHER PROCESSING |
| - | EMTRICITABINE | solution | 66406-0209DRUG FOR FURTHER PROCESSING |
| - | EPHEDRINE SULFATE | injection | 63552-282DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-135DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-136DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-137DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-138DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-139DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-140DRUG FOR FURTHER PROCESSING |
| - | ERYTHROPOIETIN | solution | 63552-141DRUG FOR FURTHER PROCESSING |
| - | ESLICARBAZEPINE ACETATE | tablet | 66406-0203DRUG FOR FURTHER PROCESSING |
| - | ESLICARBAZEPINE ACETATE | tablet | 66406-0204DRUG FOR FURTHER PROCESSING |
| - | ESLICARBAZEPINE ACETATE | tablet | 66406-0222DRUG FOR FURTHER PROCESSING |
| - | ETANERCEPT, LICENSE HOLDER UNSPECIFIED | injection, powder, lyophilized, for solution | 63552-102DRUG FOR FURTHER PROCESSING |
| - | ETELCALCETIDE HYDROCHLORIDE | solution | 63552-029DRUG FOR FURTHER PROCESSING |
| - | ETELCALCETIDE HYDROCHLORIDE | solution | 63552-030DRUG FOR FURTHER PROCESSING |
| - | ETELCALCETIDE HYDROCHLORIDE | solution | 63552-031DRUG FOR FURTHER PROCESSING |
| - | FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE | injection | 63552-026DRUG FOR FURTHER PROCESSING |
| FLUZONE HIGH DOSE NORTHERN HEMISPHERE | influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | injection, suspension, intramuscular | 63552-722BLA |
| - | FOSAPREPITANT DIMEGLUMINE | injection, powder, lyophilized, for solution | 63552-011DRUG FOR FURTHER PROCESSING |
| - | Famotidine | tablet, film coated | 66406-0100DRUG FOR FURTHER PROCESSING |
| - | Famotidine | tablet, film coated | 66406-0101DRUG FOR FURTHER PROCESSING |
| - | Famotidine | tablet, film coated | 66406-0446DRUG FOR FURTHER PROCESSING |
| - | GUANFACINE HYDROCHLORIDE | tablet, extended release | 63552-021DRUG FOR FURTHER PROCESSING |
| - | GUANFACINE HYDROCHLORIDE | tablet, extended release | 63552-022DRUG FOR FURTHER PROCESSING |
| - | GUANFACINE HYDROCHLORIDE | tablet, extended release | 63552-023DRUG FOR FURTHER PROCESSING |
| - | GUANFACINE HYDROCHLORIDE | tablet, extended release | 63552-024DRUG FOR FURTHER PROCESSING |
| - | IVABRADINE HYDROCHLORIDE | tablet, film coated | 63552-044DRUG FOR FURTHER PROCESSING |
| - | IVABRADINE HYDROCHLORIDE | tablet, film coated | 63552-045DRUG FOR FURTHER PROCESSING |
| - | Iloperidone | kit | 63285-923DRUG FOR FURTHER PROCESSING |
| - | LORATADINE | tablet, chewable | 63552-038DRUG FOR FURTHER PROCESSING |
| - | LORATADINE and pseudoephedrine sulfate | tablet, film coated, extended release | 63552-039DRUG FOR FURTHER PROCESSING |
| - | LORATADINE and pseudoephedrine sulfate | tablet, film coated, extended release | 63552-040DRUG FOR FURTHER PROCESSING |
| - | MELPHALAN HYDROCHLORIDE | injection, powder, lyophilized, for solution | 63552-076DRUG FOR FURTHER PROCESSING |
| - | MESALAMINE | capsule | 63552-042DRUG FOR FURTHER PROCESSING |
| - | MESALAMINE | capsule | 63552-043DRUG FOR FURTHER PROCESSING |
| - | Milsaperidone | kit | 63285-937DRUG FOR FURTHER PROCESSING |
| - | Milsaperidone | kit | 63285-938DRUG FOR FURTHER PROCESSING |
| - | Milsaperidone | kit | 63285-939DRUG FOR FURTHER PROCESSING |
| - | Milsaperidone | kit | 63285-940DRUG FOR FURTHER PROCESSING |
| - | Minoxidil | tablet | 66406-0045DRUG FOR FURTHER PROCESSING |
| - | Minoxidil | tablet | 66406-0046DRUG FOR FURTHER PROCESSING |
| - | Montelukast Sodium | granule | 63552-027DRUG FOR FURTHER PROCESSING |
| - | NAXITAMAB | solution, concentrate | 83266-0000DRUG FOR FURTHER PROCESSING |
| - | Naxitamab | injection | 63552-209DRUG FOR FURTHER PROCESSING |
| - | Nirogacestat | tablet, film coated | 47049-037DRUG FOR FURTHER PROCESSING |
| - | Nirogacestat | tablet, film coated | 47049-038DRUG FOR FURTHER PROCESSING |
| - | Nirsevimab | injection | 63552-207DRUG FOR FURTHER PROCESSING |
| - | Nirsevimab | injection | 63552-208DRUG FOR FURTHER PROCESSING |
| - | OXCARBAZEPINE | tablet | 66406-0244DRUG FOR FURTHER PROCESSING |
| - | OXCARBAZEPINE | tablet | 66406-0245DRUG FOR FURTHER PROCESSING |
| - | OXCARBAZEPINE | tablet | 66406-0246DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-090DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-091DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-092DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-093DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-094DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-095DRUG FOR FURTHER PROCESSING |
| - | OXYMORPHONE HYDROCHLORIDE | tablet | 63552-096DRUG FOR FURTHER PROCESSING |
| - | Omadacycline | tablet, film coated | 67651-0375DRUG FOR FURTHER PROCESSING |
| - | Oteseconazole | capsule, gelatin coated | 66406-0334DRUG FOR FURTHER PROCESSING |
| - | PRUCALOPRIDE SUCCINATE | tablet, film coated | 67651-0330DRUG FOR FURTHER PROCESSING |
| - | PRUCALOPRIDE SUCCINATE | tablet, film coated | 67651-0331DRUG FOR FURTHER PROCESSING |
| - | Peramivir | solution | 63552-077DRUG FOR FURTHER PROCESSING |
| - | Pitolisant hydrochloride | tablet, film coated | 47049-035DRUG FOR FURTHER PROCESSING |
| - | Pitolisant hydrochloride | tablet, film coated | 47049-036DRUG FOR FURTHER PROCESSING |
| - | QUIZARTINIB DIHYDROCHLORIDE | tablet, film coated | 47049-031DRUG FOR FURTHER PROCESSING |
| - | QUIZARTINIB DIHYDROCHLORIDE | tablet, film coated | 47049-032DRUG FOR FURTHER PROCESSING |
| - | RALTEGRAVIR POTASSIUM | granule, for suspension | 67651-0274DRUG FOR FURTHER PROCESSING |
| - | RALTEGRAVIR POTASSIUM | tablet, chewable | 67651-0275DRUG FOR FURTHER PROCESSING |
| - | RALTEGRAVIR POTASSIUM | tablet, chewable | 67651-0276DRUG FOR FURTHER PROCESSING |
| - | ROLAPITANT HYDROCHLORIDE | tablet | 63285-828DRUG FOR FURTHER PROCESSING |
| - | RUCAPARIB CAMSYLATE | tablet, film coated | 63285-883DRUG FOR FURTHER PROCESSING |
| - | RUCAPARIB CAMSYLATE | tablet, film coated | 63285-884DRUG FOR FURTHER PROCESSING |
| - | RUCAPARIB CAMSYLATE | tablet, film coated | 63285-885DRUG FOR FURTHER PROCESSING |
| - | RUXOLITINIB | tablet | 63552-049DRUG FOR FURTHER PROCESSING |
| - | RUXOLITINIB | tablet | 63552-050DRUG FOR FURTHER PROCESSING |
| - | RUXOLITINIB | tablet | 63552-051DRUG FOR FURTHER PROCESSING |
| - | RUXOLITINIB | tablet | 63552-052DRUG FOR FURTHER PROCESSING |
| - | RUXOLITINIB | tablet | 63552-053DRUG FOR FURTHER PROCESSING |
| - | Repotrectinib | capsule | 63285-905DRUG FOR FURTHER PROCESSING |
| - | Repotrectinib | capsule | 63285-934DRUG FOR FURTHER PROCESSING |
| - | Risperidone | injection, powder, for solution | 63552-179DRUG FOR FURTHER PROCESSING |
| - | Risperidone | injection, powder, for solution | 63552-180DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN PHOSPHATE and METFORMIN HYDROCHLORIDE | tablet, film coated, extended release | 66406-0323DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN PHOSPHATE and METFORMIN HYDROCHLORIDE | tablet, film coated, extended release | 66406-0324DRUG FOR FURTHER PROCESSING |
| - | SITAGLIPTIN PHOSPHATE and METFORMIN HYDROCHLORIDE | tablet, film coated, extended release | 66406-0325DRUG FOR FURTHER PROCESSING |
| - | SONIDEGIB PHOSPHATE | capsule | 63285-836DRUG FOR FURTHER PROCESSING |
| - | Sugammadex | injection | 63552-003DRUG FOR FURTHER PROCESSING |
| - | Sugammadex | injection | 63552-004DRUG FOR FURTHER PROCESSING |
| - | Suvorexant | tablet, film coated | 67651-0382DRUG FOR FURTHER PROCESSING |
| - | Suvorexant | tablet, film coated | 67651-0383DRUG FOR FURTHER PROCESSING |
| - | Suvorexant | tablet, film coated | 67651-0384DRUG FOR FURTHER PROCESSING |
| - | Suvorexant | tablet, film coated | 67651-0385DRUG FOR FURTHER PROCESSING |
| - | TASIMELTEON | capsule | 67651-0307DRUG FOR FURTHER PROCESSING |
| - | TENOFOVIR ALAFENAMIDE FUMARATE | tablet | 63285-797DRUG FOR FURTHER PROCESSING |
| - | TENOFOVIR DISOPROXIL FUMARATE | tablet, coated | 63285-735DRUG FOR FURTHER PROCESSING |
| - | TENOFOVIR DISOPROXIL FUMARATE | tablet, coated | 63285-736DRUG FOR FURTHER PROCESSING |
| - | TENOFOVIR DISOPROXIL FUMARATE | tablet, coated | 63285-737DRUG FOR FURTHER PROCESSING |
| - | TENOFOVIR DISOPROXIL FUMARATE | tablet, coated | 66406-0103DRUG FOR FURTHER PROCESSING |
| - | TETRAFERRIC TRICITRATE DECAHYDRATE | tablet, coated | 66406-0280DRUG FOR FURTHER PROCESSING |
| - | TOBRAMYCIN SULFATE | injection, powder, lyophilized, for solution | 63552-025DRUG FOR FURTHER PROCESSING |
| - | TRASTUZUMAB | injection, powder, lyophilized, for solution | 63552-037DRUG FOR FURTHER PROCESSING |
| - | Teclistamab | injection | 63552-197DRUG FOR FURTHER PROCESSING |
| - | Teclistamab | injection | 63552-198DRUG FOR FURTHER PROCESSING |
| - | VIGABATRIN | powder, for solution | 67651-0294DRUG FOR FURTHER PROCESSING |
| - | Valbenazine | capsule | 47049-008DRUG FOR FURTHER PROCESSING |
| - | Valbenazine | capsule | 47049-009DRUG FOR FURTHER PROCESSING |
| - | Valbenazine | capsule | 47049-021DRUG FOR FURTHER PROCESSING |
| - | Voxelotor | tablet, film coated | 66406-0301DRUG FOR FURTHER PROCESSING |
| - | Voxelotor | tablet, film coated | 66406-0442DRUG FOR FURTHER PROCESSING |
| - | WATER | injection | 63552-134DRUG FOR FURTHER PROCESSING |
| - | Water | injection | 63552-286DRUG FOR FURTHER PROCESSING |
| - | Water | injection | 63552-287DRUG FOR FURTHER PROCESSING |
| - | Ziftomenib | capsule | 63285-928DRUG FOR FURTHER PROCESSING |
| - | abiraterone acetate | tablet | 47049-061DRUG FOR FURTHER PROCESSING |
| - | abiraterone acetate | tablet | 47049-062DRUG FOR FURTHER PROCESSING |
| - | acoramidis hydrochloride | tablet, film coated | 66406-0460DRUG FOR FURTHER PROCESSING |
| - | adagrasib | tablet, coated | 63285-894DRUG FOR FURTHER PROCESSING |
| - | amifampridine phosphate | tablet | 67651-0328DRUG FOR FURTHER PROCESSING |
| - | arimoclomol citrate | capsule | 47049-049DRUG FOR FURTHER PROCESSING |
| - | arimoclomol citrate | capsule | 47049-050DRUG FOR FURTHER PROCESSING |
| - | arimoclomol citrate | capsule | 47049-051DRUG FOR FURTHER PROCESSING |
| - | arimoclomol citrate | capsule | 47049-052DRUG FOR FURTHER PROCESSING |
| - | armodafinil | tablet | 63285-030DRUG FOR FURTHER PROCESSING |
| - | armodafinil | tablet | 63285-032DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- PETNET Solutions, Inc.Cincinnati, OH · 2 sites
- Catalent Pharma Solutions Inc.Greenville, NC; Swindon, GBR · 2 sites
- Sigma-Aldrich CorporationSaint Louis, MO · 2 sites
- Contract Pharmaceuticals Limited CanadaMississauga, CAN · 2 sites
- Missouri Analytical Laboratories, Inc.Saint Louis, MO · 2 sites
- Resilience Biotechnologies Inc.Mississauga, CAN · 2 sites
- SGS North America Inc.Mississauga, CAN
- Pharmalogic Holdings Corp.Cincinnati, OH
- Synergy Health AST, LLCSwindon, GBR
- Isomedix Operations IncWhitby, CAN
- Bristol Myers Squibb CompanyManati, PR
- Allergan, Inc.Cincinnati, OH
Compare
Comparable companies in United States
- Janssen Research & Development, L.L.C.20 sites · 0 NDC
- Baxter Healthcare Corporation16 sites · 416 NDC
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- AstraZeneca PLC15 sites · 153 NDC
- Lonza Biologics Inc15 sites · 80 NDC
- Oxarc LLC15 sites · 5 NDC
- Charles River Laboratories, Inc.15 sites · 0 NDC
- Merck & Co., Inc.23 sites · 0 NDC
- AbbVie Inc.13 sites · 131 NDC
- Sigma-Aldrich Corporation13 sites · 25 NDC
Enquiry
Common questions
- Is Patheon Manufacturing Services LLC FDA approved?
- Patheon Manufacturing Services LLC holds 19 FDA-registered establishments across 9 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Patheon Manufacturing Services LLC's drugs manufactured?
- At registered sites in Australia, Austria, Canada, France, the United Kingdom, Ireland and 3 other countries. The FDA register lists Woolloongabba; Linz; Milton; Mississauga; Whitby; Bourgoin Jallieu, and 13 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.
- What drugs does Patheon Manufacturing Services LLC make?
- 319 products are listed under Patheon Manufacturing Services LLC in the openFDA NDC Directory, most often as tablet, film coated; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.